Trojan Bio
Harnessing viral specific immunity for fighting cancer
Harnessing viral specific immunity for fighting cancer
Trojan Bio is an Israeli startup founded in 2021, specializing in harnessing viral specific immunity for fighting cancer. The company's slogan, "Harnessing viral specific immunity for fighting cancer," encapsulates its mission to develop a novel class of therapeutic antibodies for treating various cancers. Trojan Bio's unique approach involves integrating viral peptides into their antibodies to efficiently activate the immune system for cancer eradication. The company operates in the industries of AI, Manufacturing, and Pharmaceutical. Trojan Bio recently secured a Pre Seed Round investment on 01 January 2022 from the venture capital firm NFX. This investment will likely fuel the further development and advancement of Trojan Bio's groundbreaking cancer treatment technology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | Unknown | 1 |
|
01 Jan 2022 |
No recent news or press coverage available for Trojan Bio.
We care about your data, and we'd love to use cookies make your experience better.
